Clinicians & Researchers

You are here

PETAL Network Bibliography

Export 16 results:

RTF
Tagged

Author Title [ Type

] Year

Filters: Author is Brown, Samuel M [Clear All Filters]

Journal Article

Admon AJ, Iwashyna TJ, Kamphuis LA, Gundel SJ, Sahetya SK, Peltan ID, Chang SY, Han JH, Vranas KC, Mayer KP et al.. 2023. Assessment of Symptom, Disability, and Financial Trajectories in Patients Hospitalized for COVID-19 at 6 Months.. JAMA Netw Open. 6(2):e2255795.

Rogers AJ, Wentworth D, Phillips A, Shaw-Saliba K, Dewar RL, Aggarwal NR, Babiker AG, Dharan NJ, Davey VJ, Higgs ES et al.. 2022. The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19.. Ann Intern Med. 175(10):1401-1410.

Peltan ID, Caldwell E, Admon AJ, Attia EF, Gundel SJ, Mathews KS, Nagrebetsky A, Sahetya SK, Ulysse C, Brown SM et al.. 2021. Characteristics and Outcomes of US Patients Hospitalized With COVID-19. American Journal of Critical Care.

Peltan ID, Caldwell E, Admon AJ, Attia EF, Gundel SJ, Mathews KS, Nagrebetsky A, Sahetya SK, Ulysse C, Brown SM et al.. 2022. Characteristics and Outcomes of US Patients Hospitalized With COVID-19. Am J Crit Care. 31(2):146-157.

Shapiro NI, Douglas IS, Brower RG, Brown SM, Exline MC, Ginde AA, Gong MN, Grissom CK, Hayden D, Hough CL et al.. 2023. Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension.. N Engl J Med.

Han JH, Ginde AA, Brown SM, Baughman A, Collar EM, E Ely W, Gong MN, Hope AA, Hou PC, Hough CL et al.. 2021. Effect of Early High-Dose Vitamin D3 Repletion on Cognitive Outcomes in Critically Ill Adults.. Chest. 160(3):909-918.

Self WH, Semler MW, Leither LM, Casey JD, Angus DC, Brower RG, Chang SY, Collins SP, Eppensteiner JC, Filbin MR et al.. 2020. Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial . JAMA.

Barkauskas C, Mylonakis E, Poulakou G, Young BE, Vock DM, Siegel L, Engen N, Grandits G, Mosaly NR, Vekstein AM et al.. 2022. Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.. Ann Intern Med. 175(9):1266-1274.

Self WH, Semler MW, Bellomo R, Brown SM, deBoisblanc BP, Exline MC, Ginde AA, Grissom CK, Janz DR, Jones AE et al.. 2018. Liberal Versus Restrictive Intravenous Fluid Therapy for Early Septic Shock: Rationale for a Randomized Trial.. Ann Emerg Med. 72(4):457-466.

Lundgren JD, Grund B, Barkauskas CE, Holland TL, Gottlieb RL, Sandkovsky U, Brown SM, Knowlton KU, Self WH, D Files C et al.. 2021. A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.. N Engl J Med. 384(10):905-914.

Brown SM, Grissom CK, Moss M, Rice TW, Schoenfeld D, Hou P, B Thompson T, Brower RG. 2016. Non-linear imputation of PaO2/FIO2 from SpO2/FIO2 among patients with Acute Respiratory Distress Syndrome.. Chest.

Sjoding MW, Schoenfeld DA, Brown SM, Hough CL, Yealy DM, Moss M, Angus DC, Iwashyna TJ. 2017. Power Calculations to Select Instruments for Clinical Trial Secondary Endpoints. A Case Study of Instrument Selection for Post-Traumatic Stress Symptoms in Subjects with Acute Respiratory Distress Syndrome.. Ann Am Thorac Soc. 14(1):110-117.

Peltan ID, McLean SR, Murnin E, Butler AM, Wilson EL, Samore MH, Hough CL, Dean NC, Bledsoe JR, Brown SM. 2022. Prevalence, Characteristics, and Outcomes of Emergency Department Discharge Among Patients With Sepsis.. JAMA Netw Open. 5(2):e2147882.

Lanspa MJ, Gong MNg, Schoenfeld DA, Lee KTiffany, Grissom CK, Hou PC, Serpa-Neto A, Brown SM, Iwashyna TJ, Yealy DM et al.. 2019. Prospective Assessment of the Feasibility of a Trial of Low-Tidal Volume Ventilation for Patients with Acute Respiratory Failure.. Ann Am Thorac Soc. 16(3):356-362.

Casey JD, Johnson NJ, Semler MW, Collins SP, Aggarwal NR, Brower RG, Chang SY, Eppensteiner J, Filbin M, Gibbs KW et al.. 2020. Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19.. Ann Am Thorac Soc. 17(9):1144-1153.

Self WH, Shotwell MS, Gibbs KW, de Wit M, D Files C, Harkins M, Hudock KM, Merck LH, Moskowitz A, Apodaca KD et al.. 2023. Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials.. JAMA. 329(14):1170-1182.